Having trouble viewing this email?View the content as a web page.

HSE Biocides ebulletin

Issued: 28 July 2023

This ebulletin contains informationonregulating biocidesin Great Britain (GB).

The GB Biocidal Products Regulation (GB BPR) operates independently from the EU Biocidal Products Regulation (EU BPR), which applies in Northern Ireland.

Separate ebulletins containing information specific to regulating biocides in Northern Ireland are issued as appropriate.

Upcoming GB active substance dossier submission deadline

Take action to keep your active substance in the GB Review Programme

The active substance/product type combination listed below has been successfully notified into the GB Review Programme following an open invitation. The next step is for a full active substance dossier to be submitted to HSE by the following deadline:

Only the person, company or task force/consortium that successfully notified the active substance/product type combination listed above can submit a dossier. If any of these active substance/product type combinations are important to you, consider contacting the notifier to let them know. You may even be able to join them in supporting the active substance.

Check the list of successful notifiers.

If a dossier is not submitted by the deadline, this active substance/product type combination will be subject to a GB non-approval decision. Biocidal products containing active substances with GB non-approval decisions for the relevant product types will have to be removed from the GB market.

HSE will provide separate updates on these where relevant.

Active substance no longer supported in GB

Non-approval decision to be taken for unsupported active substance in GB

Following an opportunity for any person, company or task force/consortium to support the active substance/product type combination listed below in the GB Review Programme, no compliant notification was received:

In cases where active substance/product type combination are not supported, GB biocides regulations require that these active substance/product type combinations are subject to a GB non-approval decision.

Once a decision is taken, biocidal products containing this active substance in the relevant product type will have to be removed from the GB market.

HSE will provide separate updates on the decision and relevant phase-out periods.

Important: If you are aware of any disproportionate negative impacts that are likely to arise from the non-approval of any of the active substance/product type combinations listed above, please contact usby 27 August 2023.